CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Riociguat

利奥西呱 杂质对照品Riociguat Impurities

EP40 个杂质条目40 impurity entries

本页汇总 利奥西呱 的 40 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 40 impurity reference standards of Riociguat with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 利奥西呱(Riociguat)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA green analytical method for identification and quantification of carcinogenic impurity N-nitroso-desformyl riociguat in riociguat formulations by UHPLC-MS/MS
    Analytical methods : advancing methods and applications · 2026 · Boddu V, Mandapaka MK  ·  PMID 42011713  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and robust optimization of the RP-HPLC method for the determination of riociguat and its four impurities in tablets using the AQbD approach
    Journal of pharmaceutical and biomedical analysis · 2025 · Rmandić M et al.  ·  PMID 39951829  ·  DOI
  3. 分析方法Analytical MethodsDetermination and pharmacokinetic study of riociguat by UPLC-MS/MS in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2022 · Kocak OF et al.  ·  PMID 36095936  ·  DOI
  4. 分析方法Analytical MethodsAnalysis of riociguat and desmethyl riociguat by UPLC-MS/MS and its interaction with quercetin
    Frontiers in pharmacology · 2024 · Li Q et al.  ·  PMID 39359248  ·  DOI
  5. 分析方法Analytical MethodsDetermination of riociguat and its major human metabolite M-1 in human plasma by stable-isotope dilution LCMS/MS
    Bioanalysis · 2015 · Gnoth MJ et al.  ·  PMID 25587836  ·  DOI

利奥西呱 —— 原料药与杂质对照品Riociguat — drug substance & impurities

共 41 个条目(含原料药本体)41 items incl. the drug substance
Riociguat structure
EP原料药 APIAPI
利奥西呱Riociguat
Riociguat
CAS No.625115-55-1
Chemical FormulaC20H19FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 1 (Riociguat EP Impurity A) structure
EPA
利奥西呱杂质1 (利奥西呱EP杂质A)Riociguat Impurity 1 (Riociguat EP Impurity A)
Riociguat Impurity 1 (Riociguat EP Impurity A)
CAS No.625115-52-8
Chemical FormulaC19H17FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 4 (Riociguat EP Impurity B) structure
EPB
利奥西呱杂质4 (利奥西呱EP杂质B)Riociguat Impurity 4 (Riociguat EP Impurity B)
Riociguat Impurity 4 (Riociguat EP Impurity B)
CAS No.3052969-92-0
Chemical FormulaC20H20N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 6 (Riociguat EP Impurity C) structure
EPC
利奥西呱杂质6 (利奥西呱EP杂质C)Riociguat Impurity 6 (Riociguat EP Impurity C)
Riociguat Impurity 6 (Riociguat EP Impurity C)
CAS No.2920299-23-4
Chemical FormulaC21H21FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 13 (Riociguat EP Impurity D) structure
EPD
利奥西呱杂质13 (利奥西呱EP杂质D)Riociguat Impurity 13 (Riociguat EP Impurity D)
Riociguat Impurity 13 (Riociguat EP Impurity D)
CAS No.625115-54-0
Chemical FormulaC22H23FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 2 structure
2
利奥西呱杂质2Riociguat Impurity 2
Riociguat Impurity 2
CAS No.1702271-98-4
Chemical FormulaC18H17FN8
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 9 structure
9
利奥西呱杂质9Riociguat Impurity 9
Riociguat Impurity 9
CAS No.256499-19-1
Chemical FormulaC14H12FN5·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 10 structure
10
利奥西呱杂质10Riociguat Impurity 10
Riociguat Impurity 10
CAS No.1361569-18-7
Chemical FormulaC19H15FN8O
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 11 structure
11
利奥西呱杂质11Riociguat Impurity 11
Riociguat Impurity 11
CAS No.1361569-23-4
Chemical FormulaC20H17FN8O
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 12 structure
12
利奥西呱杂质12Riociguat Impurity 12
Riociguat Impurity 12
CAS No.1361569-10-9
Chemical FormulaC18H13FN8O
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 15 structure
15
利奥西呱杂质15Riociguat Impurity 15
Riociguat Impurity 15
CAS No.625115-53-9
Chemical FormulaC21H21FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 17 structure
17
利奥西呱杂质17Riociguat Impurity 17
Riociguat Impurity 17
CAS No.1169770-52-8
Chemical FormulaC19H19FN8
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 18 structure
18
利奥西呱杂质18Riociguat Impurity 18
Riociguat Impurity 18
CAS No.256376-62-2
Chemical FormulaC14H11FN4O
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 19 structure
19
利奥西呱杂质19Riociguat Impurity 19
Riociguat Impurity 19
CAS No.956011-26-0
Chemical FormulaC14H10FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 20 structure
20
利奥西呱杂质20Riociguat Impurity 20
Riociguat Impurity 20
CAS No.256376-65-5
Chemical FormulaC14H9FN4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 22 structure
22
利奥西呱杂质22Riociguat Impurity 22
Riociguat Impurity 22
CAS No.2101651-50-5
Chemical FormulaC14H12FN5
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 23 structure
23
利奥西呱杂质23Riociguat Impurity 23
Riociguat Impurity 23
CAS No.2512205-25-1
Chemical FormulaC14H12FN5
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 24 structure
24
利奥西呱杂质24Riociguat Impurity 24
Riociguat Impurity 24
CAS No.6017-21-6
Chemical FormulaC9H6N4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 25 structure
25
利奥西呱杂质25Riociguat Impurity 25
Riociguat Impurity 25
CAS No.1361570-27-5
Chemical FormulaC21H21FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 27 structure
27
利奥西呱杂质27Riociguat Impurity 27
Riociguat Impurity 27
CAS No.2518331-19-4
Chemical FormulaC22H21FN8O4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 28 structure
28
利奥西呱杂质28Riociguat Impurity 28
Riociguat Impurity 28
CAS No.304874-06-4
Chemical FormulaC15H13FN4O
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 29 structure
29
利奥西呱杂质29Riociguat Impurity 29
Riociguat Impurity 29
CAS No.956010-88-1
Chemical FormulaC7H4N4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 30 structure
30
利奥西呱杂质30Riociguat Impurity 30
Riociguat Impurity 30
CAS No.428854-24-4
Chemical FormulaC17H15FN8
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 38 structure
38
利奥西呱杂质38Riociguat Impurity 38
Riociguat Impurity 38
CAS No.2101955-61-5
Chemical FormulaC21H21FN8O3
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 39 structure
39
利奥西呱杂质39Riociguat Impurity 39
Riociguat Impurity 39
CAS No.2298383-22-7
Chemical FormulaC20H19FN8O3
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 40 structure
40
利奥西呱杂质40Riociguat Impurity 40
Riociguat Impurity 40
CAS No.1356011-55-6
Chemical FormulaC21H19F3N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 41 structure
41
利奥西呱杂质41Riociguat Impurity 41
Riociguat Impurity 41
CAS No.1356011-58-9
Chemical FormulaC26H22F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 42 structure
42
利奥西呱杂质42Riociguat Impurity 42
Riociguat Impurity 42
CAS No.1356011-59-0
Chemical FormulaC21H18F4N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 43 structure
43
利奥西呱杂质43Riociguat Impurity 43
Riociguat Impurity 43
CAS No.1356011-56-7
Chemical FormulaC26H22F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 44 structure
44
利奥西呱杂质44Riociguat Impurity 44
Riociguat Impurity 44
CAS No.1361570-50-4
Chemical FormulaC22H21FN8O4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 45 structure
45
利奥西呱杂质45Riociguat Impurity 45
Riociguat Impurity 45
CAS No.1356011-57-8
Chemical FormulaC26H22F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 46 structure
46
利奥西呱杂质46Riociguat Impurity 46
Riociguat Impurity 46
CAS No.1350653-22-3
Chemical FormulaC21H17F5N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 47 structure
47
利奥西呱杂质47Riociguat Impurity 47
Riociguat Impurity 47
CAS No.2298399-34-3
Chemical FormulaC20H19FN8O3
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 48 structure
48
利奥西呱杂质48Riociguat Impurity 48
Riociguat Impurity 48
CAS No.1350653-21-2
Chemical FormulaC20H18F2N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 49 structure
49
利奥西呱杂质49Riociguat Impurity 49
Riociguat Impurity 49
CAS No.625115-56-2
Chemical FormulaC23H25FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 53 structure
53
利奥西呱杂质53Riociguat Impurity 53
Riociguat Impurity 53
CAS No.446-48-0
Chemical FormulaC7H6BrF
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 54 structure
54
利奥西呱杂质54Riociguat Impurity 54
Riociguat Impurity 54
CAS No.428854-23-3
Chemical FormulaC23H18FN9
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 57 structure
57
利奥西呱杂质57Riociguat Impurity 57
Riociguat Impurity 57
CAS No.256376-59-7
Chemical FormulaC16H14FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 63 structure
63
利奥西呱杂质63Riociguat Impurity 63
Riociguat Impurity 63
CAS No.1256833-42-7
Chemical FormulaC7H3FN4
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 71 structure
71
利奥西呱杂质71Riociguat Impurity 71
Riociguat Impurity 71
CAS No.1011527-86-8
Chemical FormulaC19H17FN8O2
Purity>95%询价On request
10mg25mg50mg100mg
Riociguat Impurity 75 structure
75
利奥西呱杂质75Riociguat Impurity 75
Riociguat Impurity 75
CAS No.1350653-31-4
Chemical FormulaC9H6N4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

利奥西呱 —— 研究文献与合成路线Riociguat — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 利奥西呱 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Riociguat. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and robust optimization of the RP-HPLC method for the determination of riociguat and its four impurities in tablets using the AQbD approach
    Rmandić M, Rašević M, Stanković J, et al. · Journal of pharmaceutical and biomedical analysis · 2025 · 被引 1cited 1
  2. A green analytical method for identification and quantification of carcinogenic impurity <i>N</i>-nitroso-desformyl riociguat in riociguat formulations by UHPLC-MS/MS
    Boddu V, Mandapaka MK · Analytical methods : advancing methods and applications · 2026
  3. Development of a CE-MS method for the study of riociguat and metabolite M1 in pharmaceutical analysis
    Štícha M, Hložek T, Bursová M, et al. · Electrophoresis · 2019 · 被引 2cited 2

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

利奥西呱 杂质谱研究要点Riociguat — impurity profiling notes

下面这些是拿到 利奥西呱 的 41 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 41 impurity entries for Riociguat, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances